Johnson & Johnson (JNJ) 105.56 $JNJ
Final Glance: Pharmaceuticals companies
AP - Wed Oct 29, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 105.56 (+0.77), BAX: 70.41 (+0.09), PFE: 29.49 (+0.40), BMY: 54.16 (-0.04)
Final Glance: Medical Devices companies
AP - Wed Oct 29, 5:02PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 108.15 (+0.05), JNJ: 105.56 (+0.77), MDT: 67.04 (+0.53), BAX: 70.41 (+0.09)
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Visa (V) Lags
at The Street - Wed Oct 29, 3:30PM CDT
The Dow component that led the way higher today was Johnson & Johnson (NYSE:JNJ), which sported a 77-cent gain (+0.7%) bringing the stock to $105.56. Holding the Dow back today was Visa (NYSE:V), which lagged the broader Dow index with a $2.05...
JNJ: 105.56 (+0.77), V: 214.66 (-2.05)
Midday Glance: Pharmaceuticals companies
AP - Wed Oct 29, 12:41PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 105.56 (+0.77), BAX: 70.41 (+0.09), PFE: 29.49 (+0.40), BMY: 54.16 (-0.04)
Midday Glance: Medical Devices companies
AP - Wed Oct 29, 12:41PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 1 p.m.:
ZMH: 108.15 (+0.05), JNJ: 105.56 (+0.77), MDT: 67.04 (+0.53), BAX: 70.41 (+0.09)
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:00PM CDT
Vertex Pharmaceuticals's (VRTX) third-quarter 2014 loss came in at 56 cents per share wider than the year-ago loss of 46 cents.
MDVN: 99.55 (-1.63), BIIB: 315.06 (-2.97), JNJ: 105.56 (+0.77), VRTX: 109.91 (-4.16)
3 Health Care Picks To Beat Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:09AM CDT
These stocks are well positioned in today's market environment.
ENDP: 65.65 (-0.93), VRX: 129.76 (-1.31), ACT: 238.78 (-0.25), AMGN: 158.88 (+1.69), TKMR: 16.87 (-1.46), GSK: 45.08 (-0.02), AGN: 186.77 (+4.17), JNJ: 105.56 (+0.77), SHPG: 196.45 (-1.35), MRK: 56.20 (+0.35), INFI: 13.58 (-0.08), ABBV: 59.98 (-0.95), KPTI: 39.81 (+1.78)
Global Beauty Care Market 2014-2018
M2 - Wed Oct 29, 10:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhgnt8/global_beauty) has announced the addition of the "Global Beauty Care Market (2014-2018)" report to their offering. The industry clocked revenues worth USD 379 billion in 2013, which is anticipated to reach USD 461 billion by 2018 The global beauty care market registered a steady Compound Annual Growth Rate (CAGR) of 4.5 percent through 2013-2018. The beauty industry was affected by the 2009 recession, but recovered quickly by 2010 as the global economy improved marginally.The global beauty care market is classified into two sub segments - premium and mass products. In 2010, the mass products segment of the global beauty care market comprised more than 70 percent, while the premium segment accounted for nearly 28 percent of the total sales. The global skin care market clocked revenues worth USD 83 billion in 2013 and with a CAGR of 5 percent through 2013-2018; the market is anticipated to garner revenues worth USD 106 billion in 2018. The facial care segment dominates the market pie with a share of more than 50 percent. Geographically, Asia-Pacific accounts for nearly 45 percent of the overall revenue generated from the skin care segment. The upturn of the global economy and the consequent rise in disposable income among consumers both in the developed and the emerging markets has propelled robust growth of the hair care market. Young people are becoming more fashion conscious and are turning to hair styling and colouring products to express their individuality. According to industry experts, the global hair care market is characterized by nearly 10,000 launches per year, representing the dynamic nature of the market. The European hair care market clocked revenues worth USD 18 billion in 2013; it is anticipated to generate revenues worth USD 24 billion in 2018. Shampoo comprises the major chunk of the EU hair care market and currently accounts for 38 percent of the segment's overall revenue. In India, the hair care products industry accrued revenues worth USD 2 billion in 2013. Market growth is expected to slow to a yearly rate of just over 10 percent between 2010 and 2018, with revenues anticipated to touch USD 3 billion by 2018. Key Topics Covered: 1. Executive Summary 2. Global Beauty Care Market 3. Global Hair Care Market 4. Global Skin Care Market 5. Global Cosmetic Care Market 6. Global Beauty Care Market 7. Major Trends 8. Key Players 9. Outlook Companies Featured: - Procter & Gamble - Kao Corporation Limited - Unilever PLC - Henkel AG & Co. KGaA - Emami Limited - Marico Limited - Oriflame Cosmetics S.A - L'Oreal S.A - Avon Products Inc - Revlon Inc - Colgate-Palmolive Co - Hypermarcas S.A - Johnson & Johnson - Beiersdorf AG - Estee Lauder Companies INC - Shiseido Co Ltd - Natura Cosmeticos S.A - Amorepacific Corporation - Kose Corp - Elizabeth Arden Inc - Reckitt Benckiser Group Plc - Fancl Corporation - Coty INC- CL A - Noevir Holding Company - Lion Corporation Limited - Ales Groupe - Steiner Leisure Limited - Coreana Cosmetics Co Ltd - Energizer Holdings Inc - Dabur India Limited For more information visit http://www.researchandmarkets.com/research/jh...bal_beauty
REV: 34.09 (+0.55), AVP: 10.96 (-0.18), COTY: 16.31 (-0.28), RDEN: 15.80 (-0.41), UL: 39.85 (-0.11), STNR: 38.94 (-1.26), ENR: 120.52 (-0.54), JNJ: 105.56 (+0.77), PG: 86.54 (+0.07), EL: 74.72 (-0.35), CL: 65.85 (+0.06)
Early Glance: Pharmaceuticals companies
AP - Wed Oct 29, 9:53AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 105.56 (+0.77), BAX: 70.41 (+0.09), PFE: 29.49 (+0.40), BMY: 54.16 (-0.04)
Early Glance: Medical Devices companies
AP - Wed Oct 29, 9:53AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
ZMH: 108.15 (+0.05), JNJ: 105.56 (+0.77), MDT: 67.04 (+0.53), BAX: 70.41 (+0.09)
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation
Thomson Reuters ONE - Wed Oct 29, 4:15AM CDT
Summary: Bavarian Nordic increases its share capital by nominally DKK 13,319,840 (1,331,984 new shares of DKK 10 each) as a result of a direct placement to Johnson & Johnson Development Corporation ("JJDC"
in connection with the license and supply agreement for the Company's MVA-BN(R) vector in respect of Ebola with Crucell Holland B.V., one of the Janssen Pharmaceutical companies of Johnson & Johnson.
JNJ: 105.56 (+0.77)
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances
PR Newswire - Tue Oct 28, 3:00PM CDT
Johnson & Johnson Innovation today announced the opening of the Asia Pacific Innovation Center, located in Shanghai with satellites in Singapore, Australia and Japan. The Asia Pacific Innovation Center extends the network of Johnson & Johnson Innovation Centers in life sciences hotspots around the globe. With local science and technology experts and deal-making capabilities, the Center will identify and develop promising early-stage opportunities across the Company's three areas of focus: Pharmaceuticals, Medical Devices and Diagnostics and Consumer healthcare products.
JNJ: 105.56 (+0.77)
Video: Facebook, Gilead Post Earnings After The Close
at Investor's Business Daily - Tue Oct 28, 1:00PM CDT
Two top stocks on Leaderboard's Leaders List report quarterly earnings after the close on Tuesday: Facebook and Gilead Sciences. Here's a breakdown of what analysts expect. The social network's earnings are seen jumping 60% to 40 cents a share minus...
JNJ: 105.56 (+0.77), GILD: 110.72 (-2.73), FB: 75.86 (-4.91), MRK: 56.20 (+0.35)
Receptos Soars After Lead Drug Racks Up Another Win
at Investor's Business Daily - Tue Oct 28, 10:46AM CDT
Receptos (RCPT) stock jumped more than 47% to a new high above 99 in morning trading on the stock market today, and the company got multiple price-target increases after its bowel-disease drug succeeded in a midstage trial. Receptos announced late...
JNJ: 105.56 (+0.77), RCPT: 98.30 (+2.54), ABBV: 59.98 (-0.95)
Final Glance: Pharmaceuticals companies
AP - Wed Oct 29, 5:02PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:
JNJ: 105.56 (+0.77), BAX: 70.41 (+0.09), PFE: 29.49 (+0.40), BMY: 54.16 (-0.04)
Final Glance: Medical Devices companies
AP - Wed Oct 29, 5:02PM CDT
NEW YORK (AP) — Shares of some top medical devices companies were mixed at the close of trading:
ZMH: 108.15 (+0.05), JNJ: 105.56 (+0.77), MDT: 67.04 (+0.53), BAX: 70.41 (+0.09)
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Leads The Day Higher, Visa (V) Lags
at The Street - Wed Oct 29, 3:30PM CDT
The Dow component that led the way higher today was Johnson & Johnson (NYSE:JNJ), which sported a 77-cent gain (+0.7%) bringing the stock to $105.56. Holding the Dow back today was Visa (NYSE:V), which lagged the broader Dow index with a $2.05...
JNJ: 105.56 (+0.77), V: 214.66 (-2.05)
Midday Glance: Pharmaceuticals companies
AP - Wed Oct 29, 12:41PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:
JNJ: 105.56 (+0.77), BAX: 70.41 (+0.09), PFE: 29.49 (+0.40), BMY: 54.16 (-0.04)
Midday Glance: Medical Devices companies
AP - Wed Oct 29, 12:41PM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 1 p.m.:
ZMH: 108.15 (+0.05), JNJ: 105.56 (+0.77), MDT: 67.04 (+0.53), BAX: 70.41 (+0.09)
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 12:00PM CDT
Vertex Pharmaceuticals's (VRTX) third-quarter 2014 loss came in at 56 cents per share wider than the year-ago loss of 46 cents.
MDVN: 99.55 (-1.63), BIIB: 315.06 (-2.97), JNJ: 105.56 (+0.77), VRTX: 109.91 (-4.16)
3 Health Care Picks To Beat Earnings - Earnings ESP
Zacks Equity Research - Zacks Investment Research - Wed Oct 29, 11:09AM CDT
These stocks are well positioned in today's market environment.
ENDP: 65.65 (-0.93), VRX: 129.76 (-1.31), ACT: 238.78 (-0.25), AMGN: 158.88 (+1.69), TKMR: 16.87 (-1.46), GSK: 45.08 (-0.02), AGN: 186.77 (+4.17), JNJ: 105.56 (+0.77), SHPG: 196.45 (-1.35), MRK: 56.20 (+0.35), INFI: 13.58 (-0.08), ABBV: 59.98 (-0.95), KPTI: 39.81 (+1.78)
Global Beauty Care Market 2014-2018
M2 - Wed Oct 29, 10:45AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jhgnt8/global_beauty) has announced the addition of the "Global Beauty Care Market (2014-2018)" report to their offering. The industry clocked revenues worth USD 379 billion in 2013, which is anticipated to reach USD 461 billion by 2018 The global beauty care market registered a steady Compound Annual Growth Rate (CAGR) of 4.5 percent through 2013-2018. The beauty industry was affected by the 2009 recession, but recovered quickly by 2010 as the global economy improved marginally.The global beauty care market is classified into two sub segments - premium and mass products. In 2010, the mass products segment of the global beauty care market comprised more than 70 percent, while the premium segment accounted for nearly 28 percent of the total sales. The global skin care market clocked revenues worth USD 83 billion in 2013 and with a CAGR of 5 percent through 2013-2018; the market is anticipated to garner revenues worth USD 106 billion in 2018. The facial care segment dominates the market pie with a share of more than 50 percent. Geographically, Asia-Pacific accounts for nearly 45 percent of the overall revenue generated from the skin care segment. The upturn of the global economy and the consequent rise in disposable income among consumers both in the developed and the emerging markets has propelled robust growth of the hair care market. Young people are becoming more fashion conscious and are turning to hair styling and colouring products to express their individuality. According to industry experts, the global hair care market is characterized by nearly 10,000 launches per year, representing the dynamic nature of the market. The European hair care market clocked revenues worth USD 18 billion in 2013; it is anticipated to generate revenues worth USD 24 billion in 2018. Shampoo comprises the major chunk of the EU hair care market and currently accounts for 38 percent of the segment's overall revenue. In India, the hair care products industry accrued revenues worth USD 2 billion in 2013. Market growth is expected to slow to a yearly rate of just over 10 percent between 2010 and 2018, with revenues anticipated to touch USD 3 billion by 2018. Key Topics Covered: 1. Executive Summary 2. Global Beauty Care Market 3. Global Hair Care Market 4. Global Skin Care Market 5. Global Cosmetic Care Market 6. Global Beauty Care Market 7. Major Trends 8. Key Players 9. Outlook Companies Featured: - Procter & Gamble - Kao Corporation Limited - Unilever PLC - Henkel AG & Co. KGaA - Emami Limited - Marico Limited - Oriflame Cosmetics S.A - L'Oreal S.A - Avon Products Inc - Revlon Inc - Colgate-Palmolive Co - Hypermarcas S.A - Johnson & Johnson - Beiersdorf AG - Estee Lauder Companies INC - Shiseido Co Ltd - Natura Cosmeticos S.A - Amorepacific Corporation - Kose Corp - Elizabeth Arden Inc - Reckitt Benckiser Group Plc - Fancl Corporation - Coty INC- CL A - Noevir Holding Company - Lion Corporation Limited - Ales Groupe - Steiner Leisure Limited - Coreana Cosmetics Co Ltd - Energizer Holdings Inc - Dabur India Limited For more information visit http://www.researchandmarkets.com/research/jh...bal_beauty
REV: 34.09 (+0.55), AVP: 10.96 (-0.18), COTY: 16.31 (-0.28), RDEN: 15.80 (-0.41), UL: 39.85 (-0.11), STNR: 38.94 (-1.26), ENR: 120.52 (-0.54), JNJ: 105.56 (+0.77), PG: 86.54 (+0.07), EL: 74.72 (-0.35), CL: 65.85 (+0.06)
Early Glance: Pharmaceuticals companies
AP - Wed Oct 29, 9:53AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:
JNJ: 105.56 (+0.77), BAX: 70.41 (+0.09), PFE: 29.49 (+0.40), BMY: 54.16 (-0.04)
Early Glance: Medical Devices companies
AP - Wed Oct 29, 9:53AM CDT
NEW YORK (AP) — Shares of some top medical devices companies are up at 10 a.m.:
ZMH: 108.15 (+0.05), JNJ: 105.56 (+0.77), MDT: 67.04 (+0.53), BAX: 70.41 (+0.09)
Capital Increase in Bavarian Nordic A/S as a Result of Completion of a Direct Placement to Johnson & Johnson Development Corporation
Thomson Reuters ONE - Wed Oct 29, 4:15AM CDT
Summary: Bavarian Nordic increases its share capital by nominally DKK 13,319,840 (1,331,984 new shares of DKK 10 each) as a result of a direct placement to Johnson & Johnson Development Corporation ("JJDC"
in connection with the license and supply agreement for the Company's MVA-BN(R) vector in respect of Ebola with Crucell Holland B.V., one of the Janssen Pharmaceutical companies of Johnson & Johnson. JNJ: 105.56 (+0.77)
Johnson & Johnson Innovation Launches Asia Pacific Innovation Center and Announces New Alliances
PR Newswire - Tue Oct 28, 3:00PM CDT
Johnson & Johnson Innovation today announced the opening of the Asia Pacific Innovation Center, located in Shanghai with satellites in Singapore, Australia and Japan. The Asia Pacific Innovation Center extends the network of Johnson & Johnson Innovation Centers in life sciences hotspots around the globe. With local science and technology experts and deal-making capabilities, the Center will identify and develop promising early-stage opportunities across the Company's three areas of focus: Pharmaceuticals, Medical Devices and Diagnostics and Consumer healthcare products.
JNJ: 105.56 (+0.77)
Video: Facebook, Gilead Post Earnings After The Close
at Investor's Business Daily - Tue Oct 28, 1:00PM CDT
Two top stocks on Leaderboard's Leaders List report quarterly earnings after the close on Tuesday: Facebook and Gilead Sciences. Here's a breakdown of what analysts expect. The social network's earnings are seen jumping 60% to 40 cents a share minus...
JNJ: 105.56 (+0.77), GILD: 110.72 (-2.73), FB: 75.86 (-4.91), MRK: 56.20 (+0.35)
Receptos Soars After Lead Drug Racks Up Another Win
at Investor's Business Daily - Tue Oct 28, 10:46AM CDT
Receptos (RCPT) stock jumped more than 47% to a new high above 99 in morning trading on the stock market today, and the company got multiple price-target increases after its bowel-disease drug succeeded in a midstage trial. Receptos announced late...
JNJ: 105.56 (+0.77), RCPT: 98.30 (+2.54), ABBV: 59.98 (-0.95)
